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Background: Functional foods with bioactive properties may help in treat obesity, as they can lead to a decreased
risks of inflammatory diseases. The aim of this study was to investigate the effects of chitosan coacervate whey
protein on the proinflammatory processes in mice fed with high-fat diet.
Methods: Mice were divided into two groups receiving either a normolipidic or high-fat diet; the animals in each
of the two diet groups were given a diet supplement of either coacervate (gavage, 36 mg protein/kg of body
weight) or tap water for four weeks [groups: normolipidic diet plus water (C); normolipidic diet and coacervate (CC);
high-fat diet and water (H); and high-fat diet and coacervate (HC)].
Results: The high-fat diet promoted inflammation, possibly by decreased adiponectin/sum of adipose tissues ratio
and increased phosphorylation of NF-κB p50. In HC we observed a positive correlation between IL-10 and TNF-α in
mesenteric adipose tissue, retroperitoneal adipose tissue and liver tissue. We also observed a positive correlation
between lipopolisaccharide with IL-10 in the liver tissue.
Conclusions: High-fat diet treatment promoted metabolic alterations and inflammation, and chitosan coacervate
whey protein modulated inflammatory milieu.
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Obesity may be partly responsible for increased oxidative
stress and consequent dysregulation of the expression of
proinflammatory adipokines in different tissues or cells,
which can trigger diseases related to metabolic syndrome
[1]. However, the mechanisms by which fat accumulation
directs the synthesis and secretion of adipokines needs to
be further investigated.
Functional foods with bioactive properties may play an
important role in combating obesity [2]. These proper-
ties may decrease the risk of diseases and enhance the
antiinflammatory pathways [3,4]. However, formulation
of functional foods with this potential is one of the chal-
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unless otherwise stated.Faced with problems related to obesity and based on
the literature, it is believed that whey protein (WP) as a
functional food may be prophylactic against obesity and
due its high nutritional value [2]. WP can act as anti-
microbial agents, antihypertensive and as regulators of
immune function, reducing body fat and may have a var-
iety of related positive effects on human health [5-8].
Moreover, WP may function as an appetite suppressant
[9] stimulating muscle protein synthesis and regulate
homeostasis [7,9-12].
Chitosan coacervate WP is composed of by-products
from the processing of shrimp, crab (chitosan) and
cheese (WP), adding an environmental benefit to the
product, as these by-products may be re-used and not
disposed of in landfill sites or released into rivers by
producers
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inflammatory state leading to insulin resistance and are
implicated in multiple inflammatory pathways, promot-
ing lipotoxicity in several target organs by direct effects
and indirectly by an alteration of gut microbiota associ-
ated with endotoxemia. Interactions between these path-
ways may perpetuate a feedback process that exacerbates
an inflammatory state [13].
Fatty acids in excess have been show to induce hepatic
insulin resistance and impair insulin clearance in vitro
and in vivo in animal models [14,15] and humans [16].
Saturated fatty acids interferes with insulin signaling pre-
dominantly via intracellular kinases, which alter insulin
receptor substrates, promoting deleterious effects in glu-
cose and lipid metabolism [17,18].
Activation of intracellular kinases, such as the inhibitor
of nuclear factor-κB kinase (IKK) and c-Jun N-terminal
kinase (JNK), Toll-like receptor 4 (TLR-4), alter insulin
receptor substrates and decrease insulin sensitivity. Add-
itionally, activation of transcription factors may contribute
to reduced glucose uptake by the expression of proinflam-
matory cytokines, such as TNF-α and IL-6, causing im-
pairment in insulin receptor phosphorylation [17].
High-fat diet can lead to a significant change in the
composition of dominant bacterial populations of gut
microflora, including a decrease in the number of Bifido-
bacteria, Eubacterium rectal-Clostridium coccoides group
and Bacteroides, favoring an increase in the gram-negative
to gram-positive ratio. The change in bacterial populations
is associated with significant increases in plasma lipo-
polysaccharide (LPS) levels, which are recognized in the
circulation (endotoxemia) by toll-like receptors in the cell
membranes and activate specific kinases, which lead to
insulin resistance. These pathways also activate NF-ĸB,
which results in the expression of inflammatory genes.
Similar to LPS, saturated fatty acids are recognized by
membrane receptors that trigger pro-inflammatory signal-
ing pathways [19,20]. The anti-inflammatory effect of adi-
ponectin has been well documented [21,22]. However the
effects of chitosan coacervate whey protein on metabolic
inflammatory pathways are not well elucidated.
Considering these complex inflammatory mechanisms,
continual investigation of functional compounds capable
of eliciting anti-inflammatory reactions and inhibiting the
inflammatory cascade signalization will aide in understand-
ing the causes of obesity and obesity-related diseases.
In addition, reviewing the literature, few scientific
studies have been conducted to date that justifies the
realization of this experimental study, with the purpose
of elucidating scientific parameters for preventing and
for therapeutics in obesity.
For this, it is necessary to understand the possible changes
involved in supplementation of chitosan coacervate WP
and proinflammatory processes triggered by high-fat diet.Materials and methods
Animals and treatment
Fifty male Swiss mice aged 51 days were acquired from
CEDEME (Centro de Desenvolvimento de Modelos
Experimentais da Universidade de São Paulo) and kept
under controlled conditions of light (12 h light–dark
cycle with lights on at 6 am) and temperature (24 ± 1°C),
in collective cages (5 mice per cage, four cages) for a
week of acclimation. After this period, all mice were
given water and food (two cages given normolipidic
(control) diet, and two high-fat diet) ad libitum for five
weeks (cycle I), followed by four weeks (cycle II) with
coacervate (36 mg/kg/day) or vehicle (tap water) treat-
ment by gavage [(C) control diet plus tap water; (CC)
control diet plus coacervate; (H) high-fat diet plus tap
water; and (HC) high-fat diet plus coacervate]. All diets
were prepared according to the recommendations of the
American Institute of Nutrition [23] (Table 1). To manu-
facture the coacervate were used: Serum sweet milk fat
free lyophilized provided by the company Libra®, chito-
san with average molecular weight, viscosity 200,000
cps, with a degree of deacetylation of 85-95% (Sigma-Al-
drich, Inc. St. Louis, MO, USA), citric acid (Lot: 40053
Fmaia industry and Trade Ltd.) and sodium hydroxide
(Lot: 109062 Merk CHEMICAL SA). The body weight
gain was monitored twice a week. The experimental re-
search committee of the Universidade Federal de São
Paulo approved all procedures for the care of the ani-
mals used in this study (CEP 114254).
Oral Glucose Tolerance Test (OGTT)
After 12 h overnight fast, blood was collected from the
tail vein to assess basal glucose concentration. Then, a
glucose (Merck®) solution (1.4 g/kg) was administrated
by gavage. Blood samples were collected after 15, 30, 43,
60 and 120 minutes to measure glucose concentration
using a glucose analyzer (AccuCheck Roche®).
Experimental procedures
At the end of the experimental period, animals were
fasted for 12 h overnight prior to being sacrificed by de-
capitation. Trunk blood was collected and immediately
centrifuged (1125 g/15 min at 4°C). Serum was separated
and stored at −80°C for later biochemical and hormonal
determination. The adipose tissue depots: retroperiton-
eal (RET), mesenteric (MES) and epididymal (EPI), and
liver were dissected, weighed, immediately frozen in li-
quid nitrogen and stored at −80°C.
Biochemical and hormonal serum analyses
Glucose, TC, TG and HDL serum concentrations were
measured by an enzymatic colorimetric method using
commercial kits (Labtest®, Brazil). Insulin and adiponectin
concentrations were quantified using specific enzyme-
Table 1 Macronutrients and micronutrients composition
of the normolipidic and high-fat diet AIN-93 M
(g/kg diet)
Nutrients Normolipidic
diet (g/kg)
High-fat
diet (g/kg)
Carbohydrates (g) 720.7 408.7
Carbohydrates (kcal) 76% 30.5%
Protein (g) 140 140
Protein (kcal) 14.5% 10.5%
Lipids (g) 40* 352†
Lipids (kcal) 9.5% 59%
Fiber (g) 50 50
Vitamin mix (g) 10 10
Mineral mix (g) 35 35
L-Cysteine (g) 1.8 1.8
Choline bitartrate (g) 2.5 2.5
Tert-butylhydroquinone (mg) 8 8
Energy value 3.8 kcal/g 5.36 kcal/g
*40 g soybean oil; †312 g lard plus 40 g soybean oil.
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R&D Systems®). The LPS level was determined using com-
mercial kits (Lonza®).
Protein analysis by Western Blotting
After euthanasia, MES was rapidly removed, homoge-
nized in 1.0 mL extraction buffer (100 mM Trizma, 1%
SDS, 100 mM sodium pyrophosphate, 100 mM sodium
fluoride, 10 mM EDTA and 10 mM sodium orthovana-
date). The extracts were then centrifuged at 20,817 g at
4°C for 40 min to separate the protein extract. Protein
determination was performed by the Bradford dye method
using the Bio-Rad reagent (Bio-Rad Laboratories®, Hercules,
CA, USA). The proteins were treated with Laemmli sample
buffer containing dithiothreitol and heated at 100°C
for 5 min before loading onto 8 or 10% SDS-PAGE in a
Bio-Rad miniature slab gel apparatus. Electrotransfer of
proteins from the gel to the nitrocellulose membrane was
performed for 1 h at 120 V (constant) in a Bio-Rad semi-
dry transfer apparatus. Nonspecific protein binding to the
nitrocellulose was reduced by pre-incubation for 2 h at
22°C in blocking buffer (1% bovine serum albumin,
10 mM Tris, 150 mM NaCl and 0.02% Tween 20). The
membranes were incubated overnight at 4°C with anti-
bodies against p-NF-kBp50 (sc-101744, diluted 1:1000),
p-NF-kBp65 (sc-71675, 1:1000), p-IκB (sc-847, 1:1000),
TLR4 (sc-10741, 1:1000), SOD-1(271014, 1:1000), GPX-3
(sc-50496, 1:1000) and α-Tubulin (sc-58667, 1:1000) ob-
tained from Santa Cruz Biotechnology® (Santa Cruz, CA,
USA), diluted in blocking buffer combined with 1% bovine
serum albumin (BSA) and then washed 3 × 10 min in
blocking buffer without BSA. The blots were subsequentlyincubated with a peroxidase-conjugated secondary anti-
body for 1 h at 22°C in blocking buffer and processed for
enhanced chemiluminescence using (Amersham ECL) to
visualize the immunoreactive bands using Uvitec Alliance
4.7 Cambridge®. Band intensities were quantified by optical
densitometry (Scion Image-Release Beta 3b, NIH, USA) of
the developed autoradiographs.
IL-6, IL-10 and TNF-α protein level determined by ELISA
Following decapitation, the adipose tissue depots RET
(0.3 g), MES (0.3 g), EPI (0.3 g), and liver (0.1 g) were
homogenized in 800 μL of chilled extraction buffer
(100 mM Trizma Base pH 7.5; 10 mM EDTA; 100 mM
NaF; 10 mM Na4P2O7; 10 mM Na3VO4; 2 mM PMSF;
0.1 mg/mL aprotinin). After homogenization, 80 μl of
10% Triton X-100 were added to the samples, which
were left in ice for 30 minutes and then centrifuged
(20,817 g, 40 minutes, 4°C). The supernatant was saved,
and protein concentration was determined using the
Bradford assay [24] (Bio-Rad, Hercules, California) with
bovine serum albumin as a reference. Quantitative assess-
ment of TNF-α, IL-6 and IL-10 proteins was carried out
by ELISA (DuoSet ELISA, R&D Systems, Minneapolis,
MN, USA) following the recommendations of the manu-
facturer. All samples were run in duplicate, and the mean
value was reported.
Statistical analysis
All results are presented as mean ± standard error of the
mean (SEM). Statistical significances were assessed using
two-way analysis of variance (ANOVA) followed by
Tukey’s post hoc analysis to identify significant differ-
ences among the groups. The Pearson’s correlation was
used to assess the associations between the analyzed vari-
ables. Differences were considered significant for (p ≤ 0.05)
with the StatsDirect® software.
Results
Body weight, delta body weight and Oral Glucose
Tolerance Test (OGTT)
Significant differences were observed in the delta (g/100 g
body weight) of cycle I, between groups C and HC (6.03 ±
0.90 vs 10.53 ± 1.46, respectively; p = 0.04). In cycle II with
gavage of coacervate we did not observe significant dif-
ferences between the groups. However, when we con-
sider the whole period of experimentation (total delta)
the HC group (16.70 ± 3.09) is statistically different when
compared to the other three groups HC vs C (6.61 ± 0.44;
p = 0.001), HC vs CC (7.53 ± 1.63; p = 0.01), HC vs H
(9.53 ± 1.63; p = 0.02) (Figure 1).
The first OGTT was performed at the end of cycle I,
but there were no significant differences in its area
under the curve (AUC). The same was observed for the
second OGTT at the end of cycle II, indicating no effect
Figure 1 Average body mass (g) per week in the experimental
groups treated with high-fat or control diet (cycle I); and
high-fat diet or control associated with gavage of water or
coacervate (cycle II); (n = 9-14). *different from C (p = 0.04); †different
from C, CC and H (p < 0.02).
Moreno et al. Nutrition & Metabolism 2014, 11:15 Page 4 of 9
http://www.nutritionandmetabolism.com/content/11/1/15of coacervate ingestion on oral glucose tolerance in mice
(data not showend).Relative weight of tissues (g/100 g body weight)
The liver relative weight in the HC group (3.24 ± 0.07)
was significantly lower than the C group (3.77 ± 0.08)
(p = 0.01). There were no differences in MES relative
weight among groups. The relative EPI was higher in
groups H (4.88 ± 0.32) (p = 0.04) and HC (4.64 ± 0.18)
(p = 0.03) versus control (3.28 ± 0.23). The RET relative
weight was higher in HC (1.32 ± 0.12) (p = 0.04) vs control
(1.0 ± 0.41). The sum of adipose tissues (SAT) relative to
weight in HC (8.84 ± 0.53) was higher (p = 0.007) vs con-
trol (5.76 ± 0.41) (data not showed).Serum cholesterol, HDL, glucose, LPS, triacylglycerol (TG),
adiponectin and insulin concentrations
Serum cholesterol, HDL, TC, LPS, glucose and insulin did
not differ among the groups, except TG in the hyper-
lipidic were lower in concentration than the control group
(H; p = 0.008) and (HC; p = 0.01).
The concentrations of adiponectin are based on the
amount of fat mass, remember this relationship is in-
versely proportional, higher values of SAT are shown
correlated with lower values of adiponectin. The ratio of
adiponectin/SAT was calculated to remove this effect
on the data. We present the values of adiponectin serum
levels and the adiponectin concentrations on the basis of
SAT and as percentage of the control amount. There
were a significant decrease in serum levels of adiponectin
in H (p = 0.02) compared with CC. The adiponectin/SAT
ratio was higher in C than in H (p < 0.003) and HC
(p = 0.01) (Table 2).Tissues cytokines content
We found that IL-6 content in RET was increased in CC
as compared to the HC (p = 0.01) group. In the MES,
the IL-6 content in CC (p = 0.03) was increased in rela-
tion to the HC group.
The IL-10/TNF-α ratio was lower, in MES of C com-
pared to H (p = 0.0009). The IL-10/TNF-α ratio in liver
tissue was increased in C compared to H (p = 0.02), and
CC was lower compared to the HC (p = 0.008).
In all tissues, TNF-α content showed no significant dif-
ferences among the C, CC, H and HC groups (Table 3).
Western blot
Following the analysis of tissues cytokines content, there
was marked an effect of the treatment in the mesenteric adi-
pose tissue deposits. Then, we studied the NF-kB complex
in this tissue. Phosphorylation of NF-kB p50 in MES was in-
creased in the groups H (p = 0.01) and HC (p = 0.003) com-
pared to C group, as verified by Western Blot (Figure 2).
Correlation between cytokines and LPS
We found positive correlations between IL-10 and TNF-α
in the HC group in adipose tissues RET (p = 0.05) (r) =
0.749, MES (p = 0.05) (r) = 0.751 and in liver tissue (p =
0.01) (r) = 0.797 (Figure 3). A positive correlation was also
observed in H (RET tissue).
A positive association between LPS with IL-10 in the
liver tissue in the HC group (Figure 4) was found when
using Person’s correlation.
Discussion
The intake of high-fat diet rich in saturated fat is associ-
ated with the pathogenesis of obesity and metabolic dis-
eases. Several methods are used to minimize the effects
of excessive body fat deposition, including foods rich in
bioactive compounds. Results from previous studies have
demonstrated the anti-obesity properties of compounds,
such as whey peptides [2,12,25].
Our results suggest that treatment of Swiss mice with
a high-fat diet for 9 weeks did not increase weight gain,
findings which support the results of previous work [26,27],
or induce significant changes in OGTT. Although the high-
fat treatment did not induce changes in glucose homeosta-
sis and weight, it was effective in triggering inflammatory
processes as was seen in the decrease adiponectin/SAT ra-
tio and the increased phosphorylation of the p50 subunit
from the NF-κB complex in MES adipose tissue.
The lipopolysaccharides (LPS) and saturated fatty acids
act on receptors of family Toll Like Receptor (TLR), in
particular TLR4, activating the track of NF-κB, which
favors the gene expression of pro-inflammatory adipo-
kines [28,29]. Signal transmission mediated by connec-
tion between LPS and TLR4 constitutes a highly complex
and varied phenomenon, mediated through reactions
Table 2 Glucose (mg/dL), TC (mg/dL), HDL (mg/dL), LPS (EU/mL), TG (mg/dL), adiponectin (ng/mL), adiponectin/sum of
adipose tissue (SAT) and insulin (ng/mL) concentrations in the experimental groups
C CC H HC
Glucose (mg/dL) 121.82 ± 11 123.77 ± 14.24 134.58 ± 10.8 132.82 ± 11.73
TC (mg/dL) 147.69 ± 7.97 135.79 ± 13.30 152.74 ± 7.73 151.37 ± 7.57
HDL (mg/dL) 64.77 ± 7.97 87.9 ± 11.25 78.51 ± 4.22 75.34 ± 4.97
LPS (EU/mL) 4.94 ± 1.85 1.90 ± 0.29 2.45 ± 0.41 2.39 ± 0.26
TG (mg/dL) 173.51 ± 10,53 160,15 ± 8,34 130.68 ± 0.54† 136.19 ± 5.17†
Adiponectin (ng/mL) 4.01 ± 0.15 4.11 ± 0.11 3.22 ± 0.22* 3.64 ± 0.22
Adiponectin/SAT (%) 101.9 ± 7.26 87 ± 8.83 54.66 ± 4.23† 59.95 ± 7.10†
Insulin (ng/mL) 0.66 ± 0.16 0.95 ± 0.22 0.75 ± 0.09 0.98 ± 0.09
Data are mean ± SEM (n = 8); †different from C (p ≤ 0,01); *different from CC (p = 0.02).
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get proteins. Specifically involved is MyD88 protein
activation of the complex IRAK (IL-1 receptor asso-
ciated Kinase) -TRAF 6 (TNF receptor-associated factor),
the latter belongs to the ubiquitin ligases class (E3 ligases)
and appearsto be essential for the NF-κB uncoupling, its
inhibitory protein (Iκ-B). NF-κB, once released, migrates
to the nucleus by binding to DNA, starting the genic amp-
lification of proteins related to inflammation [30].
TLR-4 activation by FFA or lipopolysaccharides (LPS)
in adipocytes may be involved in the development of IR
in obesity and DM2 [31,32].
Adipose tissue serves as an energy reserves in addition
to functioning as an endocrine organ which secretes pro-
teins and cytokines [33,34]. For example adiponectin,Table 3 Concentrations (pg/mg protein) TNF-α. IL-10 and IL-6
groups
MES
TNF-α C 30.97 ± 6.59
CC 51.21 ± 12
H 33.58 ± 8.02
HC 29.58 ± 5.2
IL-10 C 15.43 ± 2.75
CC 28.21 ± 7.23
H 32.39 ± 6.81
HC 23.75 ± 5.24
IL-6 C 55.05 ± 6.30
CC 74.67 ± 11.89
H 57.93 ± 11.56
HC 39.02 ± 6.73*
IL-10/TNF-α C 0.38 ± 0.08
CC 0.53 ± 0.09
H 1.19 ± 0.18†
HC 0.81 ± 0.16
Data are mean ± SEM (n = 8); †different from C (p ≤ 0.05); *different from CC (p ≤ 0.0an adipokine secreted almost exclusively by adipose
tissue increases insulin sensitivity and has anti-
atherogenic effect by reducing the inflammatory process,
and is usually found in lower amount in obese individuals
[35,36].
In this experimental study we attempted to induce
metabolic changes with the administration of a high-fat
diet to mice for five weeks and subsequently treated the
animals with chitosan coacervate WP for four more
weeks concurrently with the diet. It was expected that
the coacervate reduced body weight, similarly to other
studies of WP, but our findings for coacervate WB were
not consistent with the literature. The HC group animals
showed an increase in body weight gain compared to the
other experimental groups and SAT increased comparedin different adipose tissue and liver in the experimental
EPI RET Liver
34.87 ± 4.45 53.64 ± 9.16 2.06 ± 0.11
47.06 ± 6.39 52.18 ± 7.69 2.18 ± 0.2
30.43 ± 2.45 56 ± 9.64 2.87 ± 0.25
30.71 ± 6.84 35.15 ± 5.94 2.33 ± 0.26
17.08 ± 1.94 30.69 ± 2.96 4.87 ± 0.38
30.66 ± 2.85 32.54 ± 3.48 4.16 ± 0.42
15.47 ± 1.37 26.17 ± 3.68 4.72 ± 0.63
18.18 ± 4.95 21.6 ± 2.15 3.23 ± 0.30
41.81 ± 4.41 92.43 ± 13.83 14.86 ± 1.93
62.52 ± 5.67 114.48 ± 10.20 12.77 ± 0.48
35.27 ± 3.18 69.66 ± 14.63† 16.47 ± 1.49
36.18 ± 7.41 61.01 ± 8.67* 12.98 ± 1.37
0.52 ± 0.05 0.58 ± 0.06 2.26 ± 0.17
0.70 ± 0.06 0.59 ± 0.04 2.05 ± 0.27
0.57 ± 0.11 0.49 ± 0.03 1.64 ± 0.14†
0.49 ± 0.07 0.69 ± 0.10 1.50 ± 0.1
4).
Figure 2 Western blot analysis of p-pNF-kBp65, p-NF-kBp50, p-IκB, TLR4, GPx-3, SOD-1 protein in MES adipose tissue in different
groups. Data are mean ± SEM (n = 4–9); *different from C (p≤ 0.01).
Moreno et al. Nutrition & Metabolism 2014, 11:15 Page 6 of 9
http://www.nutritionandmetabolism.com/content/11/1/15with group C. We hypothesize that the body mass gain
of the HC animals was not due solely to fat depots, as was
evident once differences in fatty tissue between the H and
HC groups were not observed. Probably the body mass gain
could be related to the increase of body fat free mass.
Analyzing the serum lipid profile, we found that H
and HC groups showed lower concentrations of triacyl-
glycerol than group C. This result can be explained by
differences in the carbohydrate rate offers in the control
and high-fat diet, where the high fat diet groups received
a minor CHO rate. The high-fat diet possibly increased
lipoprotein lipase activity and consequently stimulated
the uptake of fatty acids by adipose tissue and reducingthe hepatic lipogenesis, resulting in a decrease in serum
TG [37,38].
The IL-10 is a pleiotropic cytokine that controls inflam-
matory processes by eliminating the pro-inflammatory cy-
tokines production such as IL-1, IL-6, IL-8 and TNF-α is
produced mainly by monocytes, macrophages, lympho-
cytes, mast cells and mature adipocytes [39]. The IL-10/
TNF-α ratio has been considered an important indicator
of inflammatory status as low values are often associated
with increased morbidity and mortality risk [40,41].
Interestingly, we observed an increase of the IL-10/
TNF-α ratio in MES of group HC despite the expectation
of finding a reduced ratio in this group. We believe that
Figure 3 Positive correlation between IL-10 and TNF-α in liver, mesenteric adipose tissue, and retroperitoneal adipose tissue.
Rows represent tissue, and columns groups (n = 7-9).
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mals may still be attempting to reverse their pro inflam-
matory state, which increased IL-10/TNF-α ratio leading
to an anti-inflammatory state. With increased length
of treatment we may have found a reduced ratio of
IL-10/TNF-α. According the results of this study coacer-
vate may have protected the mice from a pro inflamma-
tory state triggered by the treatment diet, since this ratio
was equal to the control, however, a study involving a lon-
ger treatment period may be required to discern this pos-
sible effect.
Differences between mesenteric adipose tissue and
other fatty tissues responses can be explained by the
difference in inflammatory marker secretory capacity
and in the number of resident macrophages in both
depots. Cytokine production of macrophages is higher
in MES, and these cells are important to adipose tis-
sue maintenance being highly responsive to inflamma-
tory effects [42].
Multiple intracellular pathways are involved in the se-
cretion of newly synthesized IL-10 from macrophages
following TLR4 activation with LPS, as well, trafficking
pathways for IL-6 and TNF-α in macrophages canFigure 4 Correlation between LPS and IL-10 in liver (n = 6-8).simultaneously produce pro-inflammatory cytokines
[43]. Our results support this pathway due to the finding
of a positive association between TNF-α, LPS with IL-10
in the liver tissue in the HC group. This result reinforces
the view that the increase in the IL-10 concomitantly to
LPS and TNF-α concentration is an important mechan-
ism in reversing the inflammatory process.
The treatment time and the total body composition
analysis can be considered as limitations of our study. A
longer treatment time may lead to an increase an in-
crease in body weight and alter the OGTT. Additionally,
the fat free body mass measurement can explain the
high body weight gain in the HC group. We showed the
potential positive effects of coacervate whey protein sup-
plementation on the metabolic profile and inflammatory
pathways in mice fed with high-fat diet. We also provide
evidence of the association between IL-10 and LPS in
hepatic tissue when treated with coacervate. In future in-
vestigations os the effects of coacervate whey protein we
suggest the evaluation of antioxidant enzymes activity,
which may additionally illustrate the inflammatory cas-
cade of TLR-4 activated by LPS, reflecting the endotoxe-
mia caused by high-fat diet administration.
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the adipokines, cytokines, hormones and thousands of
molecules appear to interact and play multiple roles on
several metabolic pathways. In order to further validate the
data previously presented. In addition, an analysis of correl-
ation between IL-10 and TNF-α in MES adipose tissue,
RET and liver of animals in the HC group, suggest an
increase in the production of IL-10, could be useful in
further elucidating the role of coacervate in reversing the
inflammatory effets triggered by a high-fat diet.
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